(Q40400083)

20 September 2017

Intensity-modulated radiation therapy use in the U.S., 2004. (English)

1 reference

20 September 2017

0 references

Loren K Mell

1

0 references

author name string

Amit K Mehrotra

series ordinal

2

1 reference

PubMed ID

16078260

20 September 2017

Arno J Mundt

series ordinal

3

1 reference

PubMed ID

16078260

20 September 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

20 September 2017

1 reference

20 September 2017

104

1 reference

20 September 2017

1296-1303

1 reference

20 September 2017

6

1 reference

Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy.

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

Intensity-modulated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non–small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiation therapy (IMRT) for meningioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Radiation-induced second cancers: the impact of 3D-CRT and IMRT

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

A survey of intensity-modulated radiation therapy use in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Handling missing data in survey research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Intensity-modulated radiotherapy and the Internet.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21284

7 January 2021

Identifiers

DOI

10.1002/CNCR.21284

1 reference

20 September 2017

1 reference

PubMed ID

16078260